Can Machine Learning Predict Return-to-Sport Recovery Timelines?

The cleanest machine-learning result in return-to-sport prediction comes from concussion. In a BMJ Open Sport & Exercise Medicine study, Yates and colleagues trained a Random Forest model to predict which athletes would miss more than five games after sport-related concussion. In 375 subjects, the model reported 94.6% accuracy, 100% sensitivity, and an AUC of 0.963.[1] For clinicians trying to turn sports injury updates and recovery timelines into a defensible return-to-play conversation, that is the kind of number that gets attention.

It should also make the reader slow down. A strong AUC tells us the model separated one outcome group from another in that dataset. It does not, by itself, tell us whether the model can sit inside a clinic visit, handle a different definition of recovery, account for an athlete who is physically cleared but psychologically guarded, and improve the decision that would otherwise be made by a sports medicine team.

That distinction matters because return-to-sport prediction is not the same problem as injury detection. A diagnostic model may be judged on whether it detects a current condition. A recovery-timeline model is being asked to forecast a moving target influenced by symptoms, load progression, coaching decisions, competition schedules, fear, confidence, and risk tolerance. The evidence for AI in sports injury diagnosis and prevention is useful background, but it should not be treated as evidence that timeline prediction is already solved.

What the Current Evidence Actually Covers

The 2026 systematic review by Yuan and colleagues gives the most useful map of the field. It included 11 studies of machine-learning models for return-to-sport prediction after sports injury. Random Forest appeared in 55% of the studies, making it the most common model class in this small literature. Reported sample sizes ranged from 32 to 1,611, and the best mTBI models reached AUC values up to 0.96.[2]

That combination is exactly why the field is interesting and uncomfortable. The headline performance is not trivial. Neither is the evidence base large, stable, or uniform enough to behave like practice-guideline material. The review also makes clear that studies did not define return-to-sport in one consistent way. Some outcomes tracked symptom resolution, others functional recovery, and others return to unrestricted participation.[2] Those are not interchangeable endpoints at the sideline or in the training room.

A model that predicts symptom duration may help anticipate monitoring needs. A model that predicts unrestricted competition may affect roster planning, rehabilitation pacing, and athlete counseling. A model that predicts games missed is clinically meaningful in a team-sport setting, but it can be shaped by schedule density, position demands, coaching choices, and competition level. If those endpoints are blended together, the table looks fuller than the clinical question really is.

Performance by Injury Type

The concussion literature deserves the most attention because it has both the sharpest benchmark and a second, larger replication signal. In the 971-athlete collegiate cohort, a Random Forest model classified concussion recovery as typical, defined as 28 days or less, versus prolonged, defined as more than 28 days. It reported 89% accuracy and an AUC of 0.85 across athletes from 86 sports.[3] That is not the same endpoint as the Yates study, but the direction is encouraging: Random Forest models appear able to extract meaningful recovery signals from concussion data in more than one cohort.

The differences between those two concussion studies are not bookkeeping details. “More than five games missed” and “more than 28 days” can point to overlapping athletes, but they do not measure the same thing. A five-game threshold depends on the sport calendar. A 28-day threshold is easier to compare across settings, but it can still miss the clinical texture of partial participation, modified training, symptom provocation, and delayed confidence. A model can be statistically impressive and still leave the clinician asking which practical decision it is meant to change.

Achilles rupture is the useful counterweight. The systematic review reported an XGBoost model predicting match participation after Achilles tendon rupture with an AUC of 0.81.[2] That number is credible enough to keep the conversation from becoming concussion-only, but it does not create a broad rule that machine learning can reliably forecast recovery timelines across sports injuries. Tendon rupture recovery involves surgery, loading progression, calf capacity, sport demands, and reinjury risk in a way that is not interchangeable with concussion recovery.

Why Concussion Looks Like the Best Case

Concussion gives machine learning a relatively structured prediction problem compared with many musculoskeletal injuries. There are symptom inventories, clinical assessments, time-loss outcomes, and established concern about prolonged recovery. The outcome is still messy, but the data streams are more standardized than many return-to-sport pathways. That helps explain why the best reported model performance sits in concussion and mTBI rather than in a broad, undifferentiated injury category.

The Yates model is especially striking because sensitivity was reported at 100% for predicting athletes who would miss more than five games.[1] In a clinical setting, missing a prolonged-recovery athlete is the error that creates the most immediate concern. A high-sensitivity tool could be useful if it helped clinicians identify athletes who need slower progression, closer follow-up, or earlier counseling about expectations.

But that usefulness remains conditional. The study result does not prove that ML-assisted decisions outperform standard clinical care, because the current evidence does not include prospective randomized comparisons of ML-aided return-to-play decisions against usual clinical judgment.[2] The model may be good at classification. The harder question is whether giving that classification to a clinician at the right time improves management without causing unnecessary restriction, false reassurance, or misplaced certainty.

The Missing Recovery Variable Is Often Psychological

The largest clinical gap in the literature is not a missing algorithm. It is the near-absence of psychological variables. Yuan and colleagues found that only 18% of the reviewed return-to-sport prediction studies included psychological readiness measures. When psychological variables were included, model performance improved modestly: AUC rose from 0.57 to 0.60, and sensitivity increased from 0.24 to 0.31.[2]

Those improvements are not large enough to claim that psychological data solves return-to-sport prediction. They are large enough to make exclusion hard to defend. Return to sport is not just tissue status or symptom count. Athletes hesitate, protect, catastrophize, overcompensate, underreport, and sometimes push before they trust the injured area. A model that cannot see any of that may still classify a historical endpoint, but it is looking at a thinner version of recovery than the clinician has to manage.

This is especially important when a model is used to discuss timelines. An athlete hearing “high risk for prolonged recovery” may change effort, worry, sleep, adherence, or willingness to report symptoms. An athlete hearing “likely typical recovery” may feel pressure to meet the predicted calendar. Prediction is not neutral once it enters the room. Psychological readiness, confidence, fear of reinjury, and perceived function can shape both the outcome and the athlete’s response to the forecast.

The rehabilitation literature is moving closer to this practical recovery question from another direction. AI-assisted rehabilitation studies tend to focus on intervention and outcome tracking rather than timeline prediction, so they should not be merged with return-to-sport forecasting as if they answer the same question. The companion evidence on which AI-assisted rehabilitation works best for sports injuries is relevant because prediction only becomes useful if it connects to a modifiable rehab plan.

The Numbers Are Promising, but They Are Not Yet Transportable

Three methodological problems keep the current evidence from becoming a clinical recommendation: small and uneven samples, inconsistent outcome definitions, and limited explainability. None of these cancels the positive findings. Each limits how far the findings can travel.

Small cohorts can make accuracy look more stable than it is

Across the 11 studies in the systematic review, sample sizes ranged from 32 to 1,611.[2] At the low end, a few misclassified athletes can change performance estimates meaningfully. Small datasets are also more vulnerable to local practice patterns: one clinic’s clearance process, one league’s reporting culture, one surgical protocol, or one sport’s competition calendar can become part of what the model learns.

That does not mean small studies are useless. They are often where early signals appear. But they should be read as development work, not as proof that a model is ready to determine an individual athlete’s timeline. The 971-athlete concussion study is valuable partly because it moves beyond the smallest-cohort problem, yet even that does not settle external validity across levels of play, healthcare systems, or return-to-sport protocols.[3]

The endpoint changes the clinical meaning

A return-to-sport model is only as useful as the outcome it predicts. Symptom resolution may precede full training. Full training may precede competition. Competition may occur before the athlete is performing normally. A model predicting one of those states should not be interpreted as predicting all of them.

This is why cross-study comparison is difficult in the current literature. The systematic review found varied outcome definitions across symptom resolution, functional recovery, and unrestricted competition.[2] That heterogeneity makes it risky to rank models by AUC alone. A lower AUC on a harder, more clinically meaningful endpoint may be more useful than a higher AUC on a narrower endpoint.

Explainability is still inconsistent

Clinicians do not need every model to be simple. They do need the output to be interrogable. If a model flags prolonged recovery, the next questions are immediate: Which variables drove that risk? Are they modifiable? Are they plausible? Are they proxies for something else? Can the care team explain the forecast without pretending it is a diagnosis?

The review noted that explainability approaches such as SHAP were used inconsistently across studies.[2] That matters less for a retrospective paper than it does for clinical deployment. A black-box probability may be interesting during research review; it is much less satisfying when an athlete, parent, coach, or surgeon asks why the timeline changed.

What Would Make These Models Clinically Useful?

The practical threshold is not whether a model can report a better retrospective AUC. It is whether the model improves a decision that clinicians already have to make under uncertainty. For return-to-sport timelines, that means the model should be tested at the point when timing decisions actually occur, with the information that would actually be available, and against a comparator that resembles current care.

• Prospective validation in a new clinical setting, not only internal testing or retrospective classification.
• A clearly specified endpoint, such as unrestricted competition, symptom resolution, or games missed, with no quiet switching between them.
• Inputs available at the intended decision point, so the model is not using information that would only be known later.
• Psychological readiness and athlete-reported measures included when the injury and decision context make them relevant.
• Transparent reporting of false positives and false negatives, because those errors have different consequences for safety and season planning.
• A workflow showing who sees the prediction, when it appears, and how it changes the rehabilitation or clearance discussion.

That last point is often skipped. A return-to-sport forecast is not useful simply because it exists. If the prediction arrives too late, it cannot shape rehab. If it arrives without explanation, it may not earn trust. If it arrives as a single date, it may create false precision. A probability range tied to specific modifiable factors would usually be more clinically usable than a clean but unexplained binary label.

Commercial momentum should be kept separate from this evidence threshold. Market interest in AI athlete recovery tools may grow quickly, and vendors may package prediction into dashboards, wearables, or rehabilitation platforms. That does not answer the clinical question. The question is whether the model has been validated for the injury, endpoint, population, and decision point where it will be used. AI and Healthcare: What Real Clinical Deployments Actually Look Like is the more relevant frame than market size when the output may influence clearance.

Where the Evidence Leaves Clinical Practice

Machine learning can already identify patterns in recovery data that are worth taking seriously. Random Forest models in concussion have reported AUCs from 0.85 to 0.963 in the strongest examples, and XGBoost has shown a credible signal for match participation after Achilles rupture.[1][2][3] That is enough to justify continued validation, better reporting, and careful exploration in research workflows.

It is not enough to let these tools guide individual return-to-sport decisions on their own. The current literature is too small, too heterogeneous, and too thin on psychological recovery to support that use. The models are most defensible when treated as risk-stratification research tools: potentially helpful for identifying athletes who may need closer monitoring or more conservative planning, but not as clearance engines.

The best version of this technology would not replace the clinician’s judgment. It would make the uncertainty more visible, show which factors are driving risk, and update the recovery conversation without pretending the athlete is a data point with a fixed return date. That version is promising enough to watch closely. The current evidence is not yet strong enough to trust on its own.

References

1. Machine learning prediction of prolonged recovery after sport-related concussion. BMJ Open Sport & Exercise Medicine. 2025.
2. Machine Learning for Return-to-Sport Prediction After Sports Injury: A Systematic Review. PubMed Central. 2026.
3. Machine learning identifies predictors of prolonged recovery following sport-related concussion in collegiate athletes. PubMed. 2026.